Article
The immunosuppressant FK506 uncovers a positive regulatory cross-talk between the Hog1p and Gcn2p pathways.
The Journal of biological chemistry - 5 Sept 2003
Rodriguez-Hernandez Carlos J, Sanchez-Perez Isabel, Gil-Mascarell Rosario, Rodríguez-Afonso Abigail, Torres Armando, Perona Rosario, Murguia José R
Abstract excerpt
The immunosuppressant Tacrolimus (FK506) has increased the survival rates of organ transplantation. FK506 exerts its immunosuppressive effect by inhibition of the protein phosphatase calcineurin in activated T-cells. Unfortunately, FK506 therapy is associated with undesired non-therapeutic effects involving targets other than calcineurin. To identify these targets we have addressed FK506 cellular toxicity in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
